...
首页> 外文期刊>International Journal of Surgical Oncology >The Role of Secondary Surgery in Recurrent Ovarian Cancer
【24h】

The Role of Secondary Surgery in Recurrent Ovarian Cancer

机译:二次手术在复发性卵巢癌中的作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease. Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent disease is controversial and remains a field of discussion mainly owing to missing data from prospective randomized trials. A critical review of literature evidence on secondary surgery in recurrent ovarian cancer will be described.
机译:尽管进行了最佳治疗(完全的细胞减少和辅助化疗),晚期卵巢癌的5年生存率仍约为30%,大多数患者都死于自己的疾病。细胞减少手术被认为是原发性卵巢癌的主要治疗方法,但其在复发性疾病中的作用仍存在争议,并且仍是一个讨论的领域,主要是由于前瞻性随机试验缺少数据。将描述对复发性卵巢癌进行二次手术的文献证据的综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号